Literature DB >> 7149776

Chemotherapy for advanced recurrent carcinoma of the cervix. A report on the treatment of 22 patients.

K von Maillot, I M Ranger.   

Abstract

In 22 patients with advanced squamous-cell carcinoma of the cervix, chemotherapy with adriamycin and methotrexate was attempted. Remission occurred in five patients, being complete in two of these. The median duration of remission was 8 months. In eight patients, the course of the disease was stabilized for at least 3 months. The median survival time was 3 months for the group of "failures', 11.5 months for those with stable disease, and 21 months for patients in remission. The most favourable course of the disease was observed in the two patients with complete remission; they survived for 31 and 32 months, respectively, after the start of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7149776     DOI: 10.1007/bf02111723

Source DB:  PubMed          Journal:  Arch Gynecol        ISSN: 0170-9925


  15 in total

1.  The use of Adriamycin and mehtotrexate in carcinoma of the cervix. The development of a safe effective regimen.

Authors:  D Guthrie; S Way
Journal:  Obstet Gynecol       Date:  1978-09       Impact factor: 7.661

2.  Combination chemotherapy in the treatment of advanced squamous cell carcinoma of the cervix.

Authors:  W H Bond; K Arthur; A J Banks; W E Freeman; G M Holme; G A Newsholme; H W Ward; W G Jones; M S Chowdhury; I Brown
Journal:  Clin Oncol       Date:  1976-06

3.  Adriamycin-cyclophosphamide treatment of squamous cell carcinoma of the cervix.

Authors:  D S Alberts; R Ignoffo
Journal:  Cancer Treat Rep       Date:  1978-01

Review 4.  Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinoma.

Authors:  T Thigpen; R B Vance; L Balducci; J Blessing
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

5.  Effectiveness of a sequential combination of bleomycin and mitomycin-C on an advanced cervical cancer.

Authors:  T Miyamoto; Y Takabe; M Watanabe; T Terasima
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

6.  Carcinoma of the cervix: an attempt to individualize treatment. Results of a 20-year cooperative study.

Authors:  J Zander; J Baltzer; K J Lohe; K G Ober; C Kaufmann
Journal:  Am J Obstet Gynecol       Date:  1981-04-01       Impact factor: 8.661

7.  Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? A report from the Presidential Panel at the 1979 Annual Meeting of the Society of Gynecologic Oncologists.

Authors: 
Journal:  Gynecol Oncol       Date:  1980-08       Impact factor: 5.482

8.  Low dose bleomycin and methotrexate in cervical cancer.

Authors:  J F Conroy; G C Lewis; L W Brady; I Brodsky; S B Kahn; D Ross; R Nuss
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

9.  Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group Study.

Authors:  A H Rossof; R W Talley; R Stephens; T Thigpen; M K Samson; C Groppe; H J Eyre; R Fisher
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

10.  Adriamycin plus bleomycin versus cyclophosphamide plus vincristine in advanced carcinoma of the uterine cervix.

Authors:  G M Palo; E Bajetta; G Beretta; G Bonadonna
Journal:  Tumori       Date:  1976 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.